{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T20:27:06Z","timestamp":1792268826718,"version":"4.4.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T00:00:00Z","timestamp":1737158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T00:00:00Z","timestamp":1737158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Jpn J Ophthalmol"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s10384-024-01159-y","type":"journal-article","created":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T07:28:25Z","timestamp":1737185305000},"page":"287-295","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Short-term efficacy and safety of PreserFlo MicroShunt in Japanese patients with medically treated primary open-angle glaucoma"],"prefix":"10.1007","volume":"69","author":[{"given":"Haruyuki","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1411-1476","authenticated-orcid":false,"given":"Rei","family":"Sakata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruki","family":"Yamae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukako","family":"Ishiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitomi","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megumi","family":"Honjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiroaki","family":"Shirato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Aihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,18]]},"reference":[{"key":"1159_CR1","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s10384-021-00898-6","volume":"66","author":"A Fujita","year":"2022","unstructured":"Fujita A, Hashimoto Y, Matsui H, Yasunaga H, Aihara M. Recent trends in glaucoma surgery: a nationwide database study in Japan, 2011\u20132019. Jpn J Ophthalmol. 2022;66:183\u201392.","journal-title":"Jpn J Ophthalmol"},{"key":"1159_CR2","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1001\/jamaophthalmol.2021.2351","volume":"139","author":"AK Bicket","year":"2021","unstructured":"Bicket AK, Le JT, Azuara-Blanco A, Gazzard G, Wormald R, Bunce C, et al. Minimally invasive glaucoma surgical techniques for open-angle glaucoma: an overview of cochrane systematic reviews and network meta-analysis. JAMA Ophthalmol. 2021;139:983\u20139.","journal-title":"JAMA Ophthalmol"},{"key":"1159_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.survophthal.2011.07.005","volume":"57","author":"MR Razeghinejad","year":"2012","unstructured":"Razeghinejad MR, Fudemberg SJ, Spaeth GL. The changing conceptual basis of trabeculectomy: a review of past and current surgical techniques. Surv Ophthalmol. 2012;57:1\u201325.","journal-title":"Surv Ophthalmol"},{"issue":"Pt 3","key":"1159_CR4","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/eye.1990.54","volume":"4","author":"PG Watson","year":"1990","unstructured":"Watson PG, Jakeman C, Ozturk M, Barnett MF, Barnett F, Khaw KT. The complications of trabeculectomy (a 20-year follow-up). Eye (Lond). 1990;4(Pt 3):425\u201338.","journal-title":"Eye (Lond)"},{"key":"1159_CR5","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1111\/cxo.12477","volume":"100","author":"M Pakravan","year":"2017","unstructured":"Pakravan M, Alvani A, Esfandiari H, Ghahari E, Yaseri M. Post-trabeculectomy ocular biometric changes. Clin Exp Optom. 2017;100:128\u201332.","journal-title":"Clin Exp Optom"},{"key":"1159_CR6","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3390\/jcm11010177","volume":"11","author":"Y Mizuno","year":"2021","unstructured":"Mizuno Y, Hirooka K, Kiuchi Y. Influence of overhanging bleb on corneal higher-order aberrations after trabeculectomy. J Clin Med. 2021;11:177.","journal-title":"J Clin Med"},{"key":"1159_CR7","first-page":"950","volume":"8","author":"Y Tun\u00e7","year":"2015","unstructured":"Tun\u00e7 Y, Tetikoglu M, Kara N, Sagd\u0131k HM, \u00d6zarpaci S, El\u00e7io\u011flu MN. Management of hypotony and flat anterior chamber associated with glaucoma filtration surgery. Int J Ophthalmol. 2015;8:950\u20133.","journal-title":"Int J Ophthalmol"},{"key":"1159_CR8","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1007\/s00417-023-06076-3","volume":"261","author":"N Sato","year":"2023","unstructured":"Sato N, Kasahara M, Kono Y, Hirasawa K, Shoji N. Early postoperative visual acuity changes after trabeculectomy and factors affecting visual acuity. Graefes Arch Clin Exp Ophthalmol. 2023;261:2611\u201323.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1159_CR9","doi-asserted-by":"publisher","first-page":"3916","DOI":"10.1007\/s12325-022-02230-1","volume":"39","author":"B Burgos-Blasco","year":"2022","unstructured":"Burgos-Blasco B, Garc\u00eda-Feij\u00f3o J, Perucho-Gonzalez L, G\u00fcemes-Villahoz N, Morales-Fernandez L, Mendez-Hern\u00e1ndez CD, et al. Evaluation of a novel ab externo microShunt for the treatment of glaucoma. Adv Ther. 2022;39:3916\u201332.","journal-title":"Adv Ther"},{"key":"1159_CR10","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s40662-019-0162-1","volume":"6","author":"O Sadruddin","year":"2019","unstructured":"Sadruddin O, Pinchuk L, Angeles R, Palmberg P. Ab externo implantation of the MicroShunt, a poly (styrene-block-isobutylene-block-styrene) surgical device for the treatment of primary open-angle glaucoma: a review. Eye Vis (Lond). 2019;6:36.","journal-title":"Eye Vis (Lond)"},{"key":"1159_CR11","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1001\/archopht.124.12.1742","volume":"124","author":"AC Acosta","year":"2006","unstructured":"Acosta AC, Espana EM, Yamamoto H, Davis S, Pinchuk L, Weber BA, et al. A newly designed glaucoma drainage implant made of poly(styrene-b-isobutylene-b-styrene): biocompatibility and function in normal rabbit eyes. Arch Ophthalmol. 2006;124:1742\u20139.","journal-title":"Arch Ophthalmol"},{"key":"1159_CR12","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/jbm.b.33525","volume":"105","author":"L Pinchuk","year":"2017","unstructured":"Pinchuk L, Riss I, Batlle JF, Kato YP, Martin JB, Arrieta E, et al. The development of a micro-shunt made from poly(styrene-block-isobutylene-block-styrene) to treat glaucoma. J Biomed Mater Res B Appl Biomater. 2017;105:211\u201321.","journal-title":"J Biomed Mater Res B Appl Biomater"},{"key":"1159_CR13","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1016\/j.ophtha.2021.05.023","volume":"128","author":"ND Baker","year":"2021","unstructured":"Baker ND, Barnebey HS, Moster MR, Stiles MC, Vold SD, Khatana AK, et al. Ab-Externo MicroShunt versus Trabeculectomy in Primary Open-Angle Glaucoma: one-year results from a 2-Year randomized, Multicenter Study. Ophthalmology. 2021;128:1710\u201321.","journal-title":"Ophthalmology"},{"key":"1159_CR14","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.ogla.2021.07.008","volume":"5","author":"HJM Beckers","year":"2022","unstructured":"Beckers HJM, Aptel F, Webers CAB, Bluwol E, Mart\u00ednez-de-la-Casa JM, Garc\u00eda-Feijo\u00f3 J, et al. Safety and effectiveness of the PRESERFLO\u00ae microShunt in primary open-angle glaucoma: results from a 2-year multicenter study. Ophthalmol Glaucoma. 2022;5:195\u2013209.","journal-title":"Ophthalmol Glaucoma"},{"key":"1159_CR15","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ajo.2020.02.020","volume":"215","author":"MB Schlenker","year":"2020","unstructured":"Schlenker MB, Durr GM, Michaelov E, Ahmed IIK. Intermediate outcomes of a novel standalone ab externo SIBS microshunt with mitomycin C. Am J Ophthalmol. 2020;215:141\u201353.","journal-title":"Am J Ophthalmol"},{"key":"1159_CR16","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.ogla.2023.04.002","volume":"6","author":"JJ Armstrong","year":"2023","unstructured":"Armstrong JJ, De Francesco T, Ma J, Schlenker MB, Ahmed IIK. Ab Externo SIBS microshunt with mitomycin C for open-angle glaucoma: three-year results as a primary surgical intervention. Ophthalmol Glaucoma. 2023;6:480\u201392.","journal-title":"Ophthalmol Glaucoma"},{"key":"1159_CR17","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1136\/bjophthalmol-2020-317299","volume":"106","author":"GM Durr","year":"2022","unstructured":"Durr GM, Schlenker MB, Samet S, Ahmed IIK. One-year outcomes of stand-alone ab externo SIBS microshunt implantation in refractory glaucoma. Br J Ophthalmol. 2022;106:71\u20139.","journal-title":"Br J Ophthalmol"},{"key":"1159_CR18","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.ogla.2021.08.005","volume":"5","author":"AM Fea","year":"2022","unstructured":"Fea AM, Laffi GL, Martini E, Economou MA, Caselgrandi P, Sacchi M, et al. Effectiveness of microShunt in patients with primary open-angle and pseudoexfoliative glaucoma: a retrospective European multicenter study. Ophthalmol Glaucoma. 2022;5:210\u20138.","journal-title":"Ophthalmol Glaucoma"},{"key":"1159_CR19","doi-asserted-by":"publisher","first-page":"e433","DOI":"10.1111\/aos.14602","volume":"99","author":"LMJ Scheres","year":"2021","unstructured":"Scheres LMJ, Kujovic-Aleksov S, Ramdas WD, de Crom R, Roelofs LCG, Berendschot T, et al. XEN(\u00ae) gel stent compared to PRESERFLO\u2122 MicroShunt implantation for primary open-angle glaucoma: two-year results. Acta Ophthalmol. 2021;99:e433\u201340.","journal-title":"Acta Ophthalmol"},{"key":"1159_CR20","doi-asserted-by":"publisher","first-page":"2901","DOI":"10.1007\/s00417-023-06075-4","volume":"261","author":"M Jamke","year":"2023","unstructured":"Jamke M, Herber R, Haase MA, Jasper CS, Pillunat LE, Pillunat KR. PRESERFLO \u2122 MicroShunt versus trabeculectomy: 1-year results on efficacy and safety. Graefes Arch Clin Exp Ophthalmol. 2023;261:2901\u201315.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1159_CR21","first-page":"e28288","volume":"14","author":"S Fili","year":"2022","unstructured":"Fili S, Kontopoulou K, Vastardis I, Perdikakis G, Kohlhaas M. PreserFlo\u2122 MicroShunt versus trabeculectomy in patients with moderate to advanced open-angle glaucoma: 12-month follow-up of a single-center prospective study. Cureus. 2022;14:e28288.","journal-title":"Cureus"},{"key":"1159_CR22","doi-asserted-by":"publisher","first-page":"180","DOI":"10.4103\/joco.joco_298_21","volume":"34","author":"S Fili","year":"2022","unstructured":"Fili S, Kontopoulou K, Vastardis I, Perdikakis G, Bechrakis N, Kohlhaas M. PreserFlo\u2122 MicroShunt combined with phacoemulsification versus PreserFlo\u2122 MicroShunt as a standalone procedure in patients with medically resistant open-angle glaucoma. J Curr Ophthalmol. 2022;34:180\u20136.","journal-title":"J Curr Ophthalmol"},{"key":"1159_CR23","first-page":"e35185","volume":"15","author":"KJ Habbe","year":"2023","unstructured":"Habbe KJ, Kohlhaas M, Fili S. PreserFlo\u2122 MicroShunt versus ab externo canaloplasty in patients with moderate to advanced open-angle glaucoma: 12-month follow-up of a single-center retrospective study. Cureus. 2023;15:e35185.","journal-title":"Cureus"},{"key":"1159_CR24","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/aos.15727","volume":"102","author":"AD B\u00f8hler","year":"2024","unstructured":"B\u00f8hler AD, Traustad\u00f3ttir VD, Hagem AM, T\u00f8nset TS, Drolsum L, Kristianslund O. Hypotony in the early postoperative period after MicroShunt implantation versus trabeculectomy: a registry study. Acta Ophthalmol. 2024;102:186\u201391.","journal-title":"Acta Ophthalmol"},{"key":"1159_CR25","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1038\/s41433-022-02368-w","volume":"37","author":"G Triolo","year":"2023","unstructured":"Triolo G, Wang J, Aguilar-Munoa S, Jayaram H, Barton K. Preserflo microshunt implant for the treatment of refractory uveitic glaucoma: 36-month outcomes. Eye (Lond). 2023;37:2535\u201341.","journal-title":"Eye (Lond)"},{"key":"1159_CR26","doi-asserted-by":"publisher","first-page":"4474","DOI":"10.3390\/jcm12134474","volume":"12","author":"JJ Storp","year":"2023","unstructured":"Storp JJ, Vietmeier FE, Mert\u00e9 RL, Koch R, Zimmermann JA, Eter N, et al. Long-term outcomes of the PRESERFLO MicroShunt implant in a heterogeneous glaucoma cohort. J Clin Med. 2023;12:4474.","journal-title":"J Clin Med"},{"key":"1159_CR27","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s10384-021-00893-x","volume":"66","author":"T Ahmed","year":"2022","unstructured":"Ahmed T, Honjo M, Sakata R, Fujishiro T, Shirato S, Aihara M. Long-term results of the safety and effectiveness of a novel microshunt in Japanese patients with primary open-angle glaucoma. Jpn J Ophthalmol. 2022;66:33\u201340.","journal-title":"Jpn J Ophthalmol"},{"key":"1159_CR28","first-page":"1641","volume":"111","author":"A Iwase","year":"2004","unstructured":"Iwase A, Suzuki Y, Araie M, Yamamoto T, Abe H, Shirato S, et al. The prevalence of primary open-angle glaucoma in Japanese: the Tajimi Study. Ophthalmology. 2004;111:1641\u20138.","journal-title":"Ophthalmology"},{"key":"1159_CR29","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/j.ophtha.2011.12.038","volume":"119","author":"S Sawaguchi","year":"2012","unstructured":"Sawaguchi S, Sakai H, Iwase A, Yamamoto T, Abe H, Tomita G, et al. Prevalence of primary angle closure and primary angle-closure glaucoma in a southwestern rural population of Japan: the Kumejima Study. Ophthalmology. 2012;119:1134\u201342.","journal-title":"Ophthalmology"},{"key":"1159_CR30","unstructured":"Anderson D, Patella V. Automated Static Perimetry 2nd edition. St. Louis: Mosby; 1999. pp. 121\u2013\u200990."},{"key":"1159_CR31","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1007\/s00417-019-04344-9","volume":"257","author":"A Mataftsi","year":"2019","unstructured":"Mataftsi A, Koutsimpogeorgos D, Brazitikos P, Ziakas N, Haidich AB. Is conversion of decimal visual acuity measurements to logMAR values reliable? Graefes Arch Clin Exp Ophthalmol. 2019;257:1513\u20137.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1159_CR32","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0021-5155(97)00139-1","volume":"42","author":"T Hara","year":"1998","unstructured":"Hara T, Shirato S, Suzuki Y. Ocular tissue concentrations of mitomycin C with variable dose and duration of application time in rabbits. Jpn J Ophthalmol. 1998;42:193\u20138.","journal-title":"Jpn J Ophthalmol"},{"key":"1159_CR33","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1007\/s00417-021-05215-y","volume":"259","author":"K Nakajima","year":"2021","unstructured":"Nakajima K, Sakata R, Ueda K, Fujita A, Fujishiro T, Honjo M, et al. Central visual field change after fornix-based trabeculectomy in Japanese normal-tension glaucoma patients managed under 15 mmHg. Graefes Arch Clin Exp Ophthalmol. 2021;259:2309\u201316.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1159_CR34","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/APO.0000000000000020","volume":"3","author":"N Mataki","year":"2014","unstructured":"Mataki N, Murata H, Sawada A, Yamamoto T, Shigeeda T, Araie M. Visual Field Progressive Rate in normal tension Glaucoma before and after trabeculectomy: a subfield-based analysis. Asia Pac J Ophthalmol (Phila). 2014;3:263\u20136.","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"1159_CR35","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1007\/s10384-021-00868-y","volume":"65","author":"M Aihara","year":"2021","unstructured":"Aihara M, Lu F, Kawata H, Iwata A, Odani-Kawabata N. Twelve-month efficacy and safety of omidenepag isopropyl, a selective EP2 agonist, in open-angle glaucoma and ocular hypertension: the RENGE study. Jpn J Ophthalmol. 2021;65:810\u20139.","journal-title":"Jpn J Ophthalmol"},{"key":"1159_CR36","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s00417-023-06209-8","volume":"262","author":"Y Aoyama","year":"2024","unstructured":"Aoyama Y, Sakata R, Fujishiro T, Honjo M, Shirato S, Aihara M. Contributing factors for intraocular pressure control in patients with mostly normal-tension glaucoma after initial Ex-PRESS drainage device implantation. Graefes Arch Clin Exp Ophthalmol. 2024;262:191\u2013201.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1159_CR37","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s00417-004-1088-3","volume":"243","author":"P Ehrnrooth","year":"2005","unstructured":"Ehrnrooth P, Puska P, Lehto I, Laatikainen L. Progression of visual field defects and visual loss in trabeculectomized eyes. Graefes Arch Clin Exp Ophthalmol. 2005;243:741\u20137.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1159_CR38","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/sj.eye.6700148","volume":"16","author":"B Edmunds","year":"2002","unstructured":"Edmunds B, Thompson JR, Salmon JF, Wormald RP. The national survey of trabeculectomy. III. Early and late complications. Eye (Lond). 2002;16:297\u2013303.","journal-title":"Eye (Lond)"},{"key":"1159_CR39","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.ogla.2022.11.006","volume":"6","author":"L Van Lancker","year":"2023","unstructured":"Van Lancker L, Saravanan A, Abu-Bakra M, Reid K, Quijano C, Goyal S, et al. Clinical outcomes and cost analysis of PreserFlo versus trabeculectomy for glaucoma management in the United Kingdom. Ophthalmol Glaucoma. 2023;6:342\u201357.","journal-title":"Ophthalmol Glaucoma"},{"key":"1159_CR40","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.survophthal.2013.09.003","volume":"59","author":"HK Cho","year":"2014","unstructured":"Cho HK, Kee C. Population-based glaucoma prevalence studies in asians. Surv Ophthalmol. 2014;59:434\u201347.","journal-title":"Surv Ophthalmol"},{"key":"1159_CR41","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.ophtha.2023.09.023","volume":"131","author":"JF Panarelli","year":"2024","unstructured":"Panarelli JF, Moster MR, Garcia-Feijoo J, Flowers BE, Baker ND, Barnebey HS, et al. Ab-Externo MicroShunt versus trabeculectomy in primary open-angle glaucoma: 2-year results from a randomized, multicenter study. Ophthalmology. 2024;131:266\u201376.","journal-title":"Ophthalmology"},{"key":"1159_CR42","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.ophtha.2018.12.029","volume":"126","author":"R Sakata","year":"2019","unstructured":"Sakata R, Yoshitomi T, Iwase A, Matsumoto C, Higashide T, Shirakashi M, et al. Factors associated with progression of Japanese open-angle glaucoma with lower normal intraocular pressure. Ophthalmology. 2019;126:1107\u201316.","journal-title":"Ophthalmology"},{"key":"1159_CR43","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/IJG.0000000000000145","volume":"25","author":"SK Schultz","year":"2016","unstructured":"Schultz SK, Iverson SM, Shi W, Greenfield DS. Safety and efficacy of achieving single-digit intraocular pressure targets with filtration surgery in eyes with progressive normal-tension glaucoma. J Glaucoma. 2016;25:217\u201322.","journal-title":"J Glaucoma"},{"key":"1159_CR44","doi-asserted-by":"crossref","unstructured":"Netland PA, Sarkisian SR Jr., Moster MR, Ahmed II, Condon G, Salim S et al. Randomized, prospective, comparative trial of EX-PRESS glaucoma filtration device versus trabeculectomy (XVT study). Am J Ophthalmol. 2014;157:433\u2013\u200940.e3.","DOI":"10.1016\/j.ajo.2013.09.014"},{"key":"1159_CR45","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41433-021-01888-1","volume":"37","author":"Y Aoyama","year":"2023","unstructured":"Aoyama Y, Sakata R, Fujishiro T, Honjo M, Shirato S, Aihara M. Changes in corneal endothelial cell density after initial Ex-PRESS drainage device implantation and its relating factors over 3 years. Eye (Lond). 2023;37:69\u201374.","journal-title":"Eye (Lond)"},{"key":"1159_CR46","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/j.1442-9071.2008.01683.x","volume":"36","author":"CS Kim","year":"2008","unstructured":"Kim CS, Yim JH, Lee EK, Lee NH. Changes in corneal endothelial cell density and morphology after Ahmed glaucoma valve implantation during the first year of follow up. Clin Exp Ophthalmol. 2008;36:142\u20137.","journal-title":"Clin Exp Ophthalmol"},{"key":"1159_CR47","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s40123-021-00428-0","volume":"11","author":"M Ibarz-Barber\u00e1","year":"2022","unstructured":"Ibarz-Barber\u00e1 M, Morales-Fern\u00e1ndez L, Corroto-Cuadrado A, Martinez-Gald\u00f3n F, Ta\u00f1\u00e1-Rivero P, G\u00f3mez de Lia\u00f1o R, et al. Corneal endothelial cell loss after PRESERFLO\u2122 MicroShunt implantation in the anterior chamber: anterior segment OCT tube location as a risk factor. Ophthalmol Ther. 2022;11:293\u2013310.","journal-title":"Ophthalmol Ther"}],"container-title":["Japanese Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-024-01159-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10384-024-01159-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-024-01159-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T12:02:41Z","timestamp":1744804961000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10384-024-01159-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,18]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["1159"],"URL":"https:\/\/doi.org\/10.1007\/s10384-024-01159-y","relation":{},"ISSN":["0021-5155","1613-2246"],"issn-type":[{"value":"0021-5155","type":"print"},{"value":"1613-2246","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,18]]},"assertion":[{"value":"12 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"H. Suzuki, None; R. Sakata, Royalties or licenses (Santen), Consulting fees (Santen), Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events (Santen, Senju, Otsuka, Kowa), Participation on a Data Safety Monitoring Board or Advisory Board (Santen); T. Yamae, None; Y. Ishiyama, None; K. Sugimoto, None; H. Saito, Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events (Santen, ZEISS, Otsuka, Topcon, Senju, Kowa, Novartis, AbbVie, Viatris, Sandoz, ROHTO); M. Honjo, Grants or contracts (Santen, Alcon), Payment or honoraria for lectures, presentations, speaker bureaus, manuscript writing or educational events (Santen, Otsuka, Kowa, Novartis), Participation on a Data Safety Monitoring Board or Advisory Board (Santen), Receipt of equipment, materials, drugs, medical writing, gifts or other services (Santen, Kowa); S. Shirato, Consulting fees (Santen, Senju, Kowa, Otsuka); M. Aihara, Grants or contracts (Santen, Alcon, Pfizer, Otsuka, Johnson & Johnson, TOMEY, CREWT Medical Systems, Senju, Novartis, Kowa, Wakamoto, Glaukos, Ono, Sato), Consulting fees (Santen, Alcon, Kowa, Wakamoto, Glaukos, Astellas, Senju, Pfizer, Otsuka, HOYA, IRIDEX Medical Systems), Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events (Santen, Pfizer, Otsuka, Johnson & Johnson, TOMEY, CREWT Medical Systems, Senju, Wakamoto, Glaukos, Astellas, HOYA, IRIDEX Medical Systems, Novartis, Alcon, CANON, ZEISS, Sato), Participation on a Data Safety Monitoring Board or Advisory Board (Santen, Senju, Kowa), Receipt of equipment, materials, drugs, medical writing, gifts or other services (Kowa, Santen).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}